JPH07103134B2 - Phosphate ester - Google Patents
Phosphate esterInfo
- Publication number
- JPH07103134B2 JPH07103134B2 JP13381591A JP13381591A JPH07103134B2 JP H07103134 B2 JPH07103134 B2 JP H07103134B2 JP 13381591 A JP13381591 A JP 13381591A JP 13381591 A JP13381591 A JP 13381591A JP H07103134 B2 JPH07103134 B2 JP H07103134B2
- Authority
- JP
- Japan
- Prior art keywords
- alkaline phosphatase
- compound
- substrate
- solution
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- -1 Phosphate ester Chemical class 0.000 title claims description 9
- 229910019142 PO4 Inorganic materials 0.000 title description 7
- 239000010452 phosphate Substances 0.000 title description 6
- 239000000126 substance Substances 0.000 claims description 16
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 9
- 229910052801 chlorine Inorganic materials 0.000 claims description 4
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 4
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims description 3
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical group [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 2
- 229910052708 sodium Inorganic materials 0.000 claims description 2
- 125000004436 sodium atom Chemical group 0.000 claims description 2
- 150000003014 phosphoric acid esters Chemical class 0.000 claims 1
- 238000000034 method Methods 0.000 description 38
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 35
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 35
- 150000001875 compounds Chemical class 0.000 description 28
- 239000000758 substrate Substances 0.000 description 28
- 239000000243 solution Substances 0.000 description 26
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 18
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 239000000975 dye Substances 0.000 description 12
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 10
- 108090000790 Enzymes Proteins 0.000 description 10
- 230000009471 action Effects 0.000 description 10
- 239000013078 crystal Substances 0.000 description 10
- 230000000694 effects Effects 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 229940126214 compound 3 Drugs 0.000 description 9
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000006911 enzymatic reaction Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000004737 colorimetric analysis Methods 0.000 description 7
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 6
- 239000000987 azo dye Substances 0.000 description 6
- 235000021317 phosphate Nutrition 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 238000002835 absorbance Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 230000007062 hydrolysis Effects 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- WVLBCYQITXONBZ-UHFFFAOYSA-N trimethyl phosphate Chemical compound COP(=O)(OC)OC WVLBCYQITXONBZ-UHFFFAOYSA-N 0.000 description 5
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- GHYOCDFICYLMRF-UTIIJYGPSA-N (2S,3R)-N-[(2S)-3-(cyclopenten-1-yl)-1-[(2R)-2-methyloxiran-2-yl]-1-oxopropan-2-yl]-3-hydroxy-3-(4-methoxyphenyl)-2-[[(2S)-2-[(2-morpholin-4-ylacetyl)amino]propanoyl]amino]propanamide Chemical compound C1(=CCCC1)C[C@@H](C(=O)[C@@]1(OC1)C)NC([C@H]([C@@H](C1=CC=C(C=C1)OC)O)NC([C@H](C)NC(CN1CCOCC1)=O)=O)=O GHYOCDFICYLMRF-UTIIJYGPSA-N 0.000 description 3
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- LDKDGDIWEUUXSH-UHFFFAOYSA-N Thymophthalein Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3C(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C LDKDGDIWEUUXSH-UHFFFAOYSA-N 0.000 description 3
- 229940125797 compound 12 Drugs 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 230000035945 sensitivity Effects 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- 229920000858 Cyclodextrin Polymers 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- VCCIAAPOKIZVON-UHFFFAOYSA-N [4-[3-(4-hydroxy-2-methyl-5-propan-2-ylphenyl)-1,1-dioxo-2,1$l^{6}-benzoxathiol-3-yl]-5-methyl-2-propan-2-ylphenyl] dihydrogen phosphate Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(OP(O)(O)=O)=C(C(C)C)C=2)C)=C1C VCCIAAPOKIZVON-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- VIYFPAMJCJLZKD-UHFFFAOYSA-L disodium;(4-nitrophenyl) phosphate Chemical compound [Na+].[Na+].[O-][N+](=O)C1=CC=C(OP([O-])([O-])=O)C=C1 VIYFPAMJCJLZKD-UHFFFAOYSA-L 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910001629 magnesium chloride Inorganic materials 0.000 description 2
- 239000012046 mixed solvent Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000011002 quantification Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- NCPBESHYZRJICR-UHFFFAOYSA-N 1-dichlorophosphoryloxy-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(OP(Cl)(Cl)=O)C=C1 NCPBESHYZRJICR-UHFFFAOYSA-N 0.000 description 1
- XNWFRZJHXBZDAG-UHFFFAOYSA-N 2-METHOXYETHANOL Chemical compound COCCO XNWFRZJHXBZDAG-UHFFFAOYSA-N 0.000 description 1
- BWGRDBSNKQABCB-UHFFFAOYSA-N 4,4-difluoro-N-[3-[3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-thiophen-2-ylpropyl]cyclohexane-1-carboxamide Chemical compound CC(C)C1=NN=C(C)N1C1CC2CCC(C1)N2CCC(NC(=O)C1CCC(F)(F)CC1)C1=CC=CS1 BWGRDBSNKQABCB-UHFFFAOYSA-N 0.000 description 1
- XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 1
- ZEPAOUCWIQXIDU-UHFFFAOYSA-N 4-[(2-methylsulfonyl-4-nitrophenyl)diazenyl]phenol Chemical compound CS(=O)(=O)C1=CC([N+]([O-])=O)=CC=C1N=NC1=CC=C(O)C=C1 ZEPAOUCWIQXIDU-UHFFFAOYSA-N 0.000 description 1
- RXQNKKRGJJRMKD-UHFFFAOYSA-N 5-bromo-2-methylaniline Chemical compound CC1=CC=C(Br)C=C1N RXQNKKRGJJRMKD-UHFFFAOYSA-N 0.000 description 1
- 238000008940 Alkaline Phosphatase assay kit Methods 0.000 description 1
- 229920001450 Alpha-Cyclodextrin Polymers 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- WMDDNKROYKCDJC-UHFFFAOYSA-N [4-[3-oxo-1-(4-phosphonooxyphenyl)-2-benzofuran-1-yl]phenyl] dihydrogen phosphate Chemical compound C1=CC(OP(O)(=O)O)=CC=C1C1(C=2C=CC(OP(O)(O)=O)=CC=2)C2=CC=CC=C2C(=O)O1 WMDDNKROYKCDJC-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000032900 absorption of visible light Effects 0.000 description 1
- 238000000862 absorption spectrum Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- HFHDHCJBZVLPGP-RWMJIURBSA-N alpha-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO HFHDHCJBZVLPGP-RWMJIURBSA-N 0.000 description 1
- 229940043377 alpha-cyclodextrin Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- JFEVWPNAOCPRHQ-UHFFFAOYSA-N chembl1316021 Chemical compound OC1=CC=CC=C1N=NC1=CC=CC=C1O JFEVWPNAOCPRHQ-UHFFFAOYSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 229940097362 cyclodextrins Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 125000000664 diazo group Chemical group [N-]=[N+]=[*] 0.000 description 1
- WVPKAWVFTPWPDB-UHFFFAOYSA-M dichlorophosphinate Chemical compound [O-]P(Cl)(Cl)=O WVPKAWVFTPWPDB-UHFFFAOYSA-M 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 125000006575 electron-withdrawing group Chemical group 0.000 description 1
- 239000003248 enzyme activator Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 150000004712 monophosphates Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 201000008968 osteosarcoma Diseases 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- CMPQUABWPXYYSH-UHFFFAOYSA-N phenyl phosphate Chemical compound OP(O)(=O)OC1=CC=CC=C1 CMPQUABWPXYYSH-UHFFFAOYSA-N 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000012113 quantitative test Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- RUYANEADGUFWRJ-UHFFFAOYSA-M sodium;(4-nitrophenyl) hydrogen phosphate Chemical compound [Na+].OP([O-])(=O)OC1=CC=C([N+]([O-])=O)C=C1 RUYANEADGUFWRJ-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 238000007039 two-step reaction Methods 0.000 description 1
Landscapes
- Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Description
【産業上の利用分野】本発明は新規なリン酸モノエステ
ルに関するものである。さらに詳しくは、アルカリ性ホ
スファターゼの作用により加水分解されてアゾ色素を放
出する新規なモノ−4−アリールアゾアリールリン酸エ
ステルに関するものである。FIELD OF THE INVENTION The present invention relates to a novel phosphoric acid monoester. More specifically, it relates to a novel mono-4-arylazoaryl phosphate ester which is hydrolyzed by the action of alkaline phosphatase to release an azo dye.
【従来の技術】人の体液中のアルカリ性ホスファターゼ
の活性を知ることは臨床検査上極めて重要である。すな
わち、一般にアルカリ性ホスファターゼの活性が高い時
は、肝臓、骨等の新陳代謝が不順な状態にあり、肝臓
病、くる病、骨肉腫、甲状腺異常などの症状が現われる
ことはよく知られている。従ってアルカリ性ホスファタ
ーゼの活性を測定するための種々の方法が考え出されて
いることは極めて当然なことである。日常の臨床検査に
おけるアルカリ性ホスファターゼ定量法としては操作が
簡単でしかも再現性の良いことが必要であるが、この目
的にはいわゆる比色法とケイ光法とがある。すなわち、
比色法とは、アルカリ性ホスファターゼの作用によって
加水分解されて色素あるいは色素の前駆体を放出する化
合物を酵素反応の基質として用い、酵素反応の結果放出
される色素を比色定量することにより、あるいは酵素反
応の結果放出される色素前駆体を、試薬を加えて化学反
応させて色素に変え、その色素を比色定量することによ
りアルカリ性ホスファターゼの活性度を知る方法であ
り、広く普及している比色計あるいは分光光度計を用い
て定量できるという利点がある。一方ケイ光法とは、ア
ルカリ性ホスファターゼの作用によって加水分解され
て、発ケイ光物質を放出する化合物を酵素反応の基質と
して用い、酵素反応の結果放出される発ケイ光物質のケ
イ光強度を測定することによりアルカリ性ホスファター
ゼの活性度を知る方法であり、比色法に比べて感度が高
いが微量の共存する発ケイ光物質による妨害を受けやす
いことおよびケイ光光度計があまり普及していないとい
う難点がある。本発明は比色法によるアルカリ性ホスフ
ァターゼの定量法において好適な基質となる新規化合物
モノ−4−アリールアゾアリールリン酸エステルに関す
るものである。従来、比色法によるアルカリ性ホスファ
ターゼの定量法として次の方法が用いられていた。 (1) p−ニトロフェニルリン酸二ナトリウムを基質
として用い、アルカリ性ホスファターゼの作用による加
水分解の結果放出されるp−ニトロフェノールを比色定
量する方法であり、具体的方法についてはO.A.Be
ssey,O.H.Lowry,およびM.J.Bro
ck著、Journal of Biological
Chemistry誌 第164巻、321頁(19
46年発行)に記載されている。 (2) リン酸フェノールフタレインを基質として用
い、アルカリ性ホスファターゼの作用による加水分解の
結果放出されるフェノールフタレインを比色定量する方
法であり、具体的にはA.L.Babson,S.J.
Greeley,C.M.Coleman,およびG.
E.Phillips著、ClinicalChemi
stry誌、第12巻、482頁(1966年発行)に
記載されている。 (3) リン酸チモールフタレインを基質として用い、
アルカリ性ホスファターゼの作用による加水分解の結果
放出されるチモールフタレインを比色定量する方法であ
り、具体例はC.M.Colemann Clinic
al Chemistry誌、第13巻、401頁(1
966年発行)に記載されている。 (4) チモールブルーモノホスフェイトを基質として
用い、アルカリ性ホスファターゼの作用による加水分解
の結果放出されるチモールブルーを比色定量する方法で
あり、具体例は特開昭51−136662号に記載され
ている。 (5) フェニルリン酸を基質として用い、アルカリ性
ホスファターゼの作用による加水分解の結果放出される
フェノールを、赤血塩の存在下で4−アミノアンチピリ
ンと酸化縮合させ、生じた赤色キノンを比色定量する方
法で、具体例としては、P.R.N.Kind,および
E.J.King著、ClinicalPatholo
gy誌、第7巻、322頁(1954年発行);渡辺賢
誠ほか著、「臨床病理」誌、第15巻、708頁(19
67年発行)中山年正ほか著「臨床病理」誌、第23巻
(総会補冊)85頁(1975年発行)に記載されてい
る。 以上に述べた従来法のうち(1)の方法はアルカリ性ホ
スファターゼの定量法として最も広く用いられている
が、比色波長が410nmであるため血清中のビリルビ
ンやヘモグロビンなどの有色物による妨害を免れず、検
体盲検が必要となり、それだけ操作が繁雑になる欠点が
あった。従来法(2)〜(5)の方法においては、比色
波長がさらに長波領域にあるためこの欠点は一応克服さ
れている。しかしながら、フタレイン類のモノリン酸エ
ステルを基質とする(2)、(3)および(4)の方法
においては純度の高い基質を合成することが難しい。つ
まり、これらのモノリン酸エステルは対応するフタレイ
ンを分子中の1個の水酸基をオキシ塩化リンと反応させ
て得られるフタレインのモノホスホロジクロリデートを
加水分解して合成するが、フタレインに対するオキシ塩
化リンの量が多いとフタレイン分子中の2個の水酸基が
ホスホリル化されてしまい、またフタレインに対するオ
キシ塩化リンの量が少ないとオキシ塩化リン1分子に対
してフタレインが2分子あるいは3分子反応するので生
成物が2種あるいは3種も生成してしまう。いずれの場
合にもアルカリ性ホスファターゼの定量用基質として不
適当な化合物が副生する。したがって反応後の単離精製
が繁雑になり、純度の高い生成物を多く手に入れること
が困難であった。一方、従来法(5)の方法においては
フェノールを遊離させる酵素反応と発色反応との2段階
の反応過程を経ることが必要であるため操作もそれだけ
繁雑であった。このため以上のような欠点のないアルカ
リ性ホスファターゼ定量法の出現が望まれていた。2. Description of the Related Art It is extremely important for clinical examination to know the activity of alkaline phosphatase in human body fluid. That is, it is well known that when the activity of alkaline phosphatase is generally high, the metabolism of the liver, bone and the like is disordered and symptoms such as liver disease, rickets, osteosarcoma and thyroid abnormalities appear. Therefore, it is quite natural that various methods have been devised for measuring the activity of alkaline phosphatase. The alkaline phosphatase quantification method in daily clinical tests requires simple operation and good reproducibility. For this purpose, there are so-called colorimetric method and fluorescent method. That is,
The colorimetric method uses a compound that is hydrolyzed by the action of alkaline phosphatase to release a dye or a precursor of a dye as a substrate for an enzymatic reaction, and colorimetrically quantifies the dye released as a result of the enzymatic reaction, or This is a method to know the activity of alkaline phosphatase by colorimetrically determining the dye precursor that is released as a result of enzymatic reaction by chemically reacting it with a reagent and colorimetrically determining it. It has the advantage that it can be quantified using a colorimeter or a spectrophotometer. On the other hand, the fluorescent method uses a compound that is hydrolyzed by the action of alkaline phosphatase and releases a fluorescent substance as a substrate for an enzymatic reaction, and measures the fluorescent intensity of the fluorescent substance released as a result of the enzymatic reaction. It is a method of knowing the activity of alkaline phosphatase by doing so, and it has higher sensitivity than the colorimetric method, but it is susceptible to interference by a small amount of coexisting fluorescent substance and that the fluorometer is not widely used. There are difficulties. The present invention relates to a novel compound, a mono-4-arylazoaryl phosphate ester, which is a suitable substrate in a colorimetric assay for alkaline phosphatase. Conventionally, the following method has been used as a method for quantifying alkaline phosphatase by a colorimetric method. (1) This is a method for colorimetrically quantifying p-nitrophenol released as a result of hydrolysis by the action of alkaline phosphatase using p-nitrophenyl phosphate disodium as a substrate. A. Be
sey, O.S. H. Lowry, and M.M. J. Bro
ck, Journal of Biological
Chemistry, Volume 164, p. 321 (19
Issued in 1946). (2) A method for colorimetrically quantifying phenolphthalein released as a result of hydrolysis by the action of alkaline phosphatase using phenolphthalein phosphate as a substrate. L. Babson, S .; J.
Greeney, C.I. M. Coleman, and G.G.
E. Phillips, Clinical Chemi
It is described in the magazine, p. 482, published in 1966 (published in 1966). (3) Using thymolphthalein phosphate as a substrate,
It is a method for colorimetrically determining thymolphthalein released as a result of hydrolysis by the action of alkaline phosphatase. M. Colemann Clinic
al Chemistry, vol. 13, p. 401 (1
966). (4) A method for colorimetrically determining thymol blue released as a result of hydrolysis by the action of alkaline phosphatase using thymol blue monophosphate as a substrate, and a specific example thereof is described in JP-A-51-136662. There is. (5) Using phenyl phosphate as a substrate, the phenol released as a result of hydrolysis by the action of alkaline phosphatase is oxidatively condensed with 4-aminoantipyrine in the presence of red blood salt, and the resulting red quinone is colorimetrically determined. As a specific example, the method described in P. R. N. Kind, and E. J. King, Clinical Patholo
gy, Vol. 7, p. 322 (published in 1954); Kensei Watanabe et al., "Clinical Pathology", vol. 15, p. 708 (19).
1987) Toshimasa Nakayama et al., "Clinical Pathology", Vol. 23 (Summary of General Assembly), page 85 (issued in 1975). Among the conventional methods described above, the method (1) is most widely used as a method for quantifying alkaline phosphatase, but since the colorimetric wavelength is 410 nm, it is free from interference by colored substances such as bilirubin and hemoglobin in serum. However, there was a drawback that the sample blinding was required and the operation was complicated accordingly. In the conventional methods (2) to (5), since the colorimetric wavelength is in the long wave region, this drawback has been overcome. However, it is difficult to synthesize a highly pure substrate by the methods (2), (3) and (4) using a monophosphate ester of phthaleins as a substrate. In other words, these monophosphates are synthesized by hydrolyzing the corresponding monophthalodichloridate of phthalein obtained by reacting the corresponding phthalein with one hydroxyl group in the molecule with phosphorus oxychloride. If the amount of phthalein is large, the two hydroxyl groups in the phthalein molecule will be phosphorylated, and if the amount of phosphorus oxychloride to phthalein is small, 2 or 3 molecules of phthalein will react with 1 molecule of phosphorus oxychloride. Two or three kinds of things are generated. In any case, a compound unsuitable as a substrate for quantifying alkaline phosphatase is by-produced. Therefore, isolation and purification after the reaction became complicated, and it was difficult to obtain many highly pure products. On the other hand, in the method of the conventional method (5), it was necessary to go through a two-step reaction process of an enzyme reaction for liberating phenol and a color reaction, and the operation was so complicated. Therefore, the advent of an alkaline phosphatase assay method that does not have the above-mentioned drawbacks has been desired.
【発明が解決しようとする課題】したがって、本発明の
目的は測定の際の操作性に優れ、かつ血中の色素等の有
色物による妨害を受け難く、検出感度も優れ、しかも合
成および精製に難点がないアルカリ性ホスファターゼ定
量用基質として有用な新規化合物を提供することであ
る。Therefore, the object of the present invention is to have excellent operability during measurement, to be less susceptible to interference by colored substances such as dyes in blood, to have excellent detection sensitivity, and to be used for synthesis and purification. It is an object of the present invention to provide a novel compound which is useful as a substrate for quantifying alkaline phosphatase without difficulty.
【課題を解決するための手段】上記の目的は、下記の一
般式(I)または(II)で示される新規なモノ−4−
アリールアゾアリールリン酸エステルによって効果的に
達成され得ることを見出した。The above-mentioned object is to provide a novel mono-4- represented by the following general formula (I) or (II).
It has been found that it can be effectively achieved with arylazoaryl phosphates.
【化2】 (式中、Mは水素原子、ナトリウム原子またはカリウム
原子であり、R1とR2の一方はメチルスルホニル基、
R1とR2の他方はニトロ基であり、R3は塩素原子ま
たは水素原子、R4は水素原子、ヒドロキシル基、メチ
ル基またはメチルカルボニルアミノ基であり、R5は水
素原子または塩素原子であり、R6はメチル基または3
−スルファモイルフェニル基である。)一般式(I)ま
たは(II)で表わされる化合物はいずれもアルカリ性
ホスファターゼの作用によってアルカリ性ホスファター
ゼの活性に比例した速度で加水分解されて対応するアゾ
色素を放出するため、アルカリ性ホスファターゼの定量
用基質として用いることができる。特に一般式(I)に
おいてR4及びR5が水素原子である化合物は、原料入
手し易く、また、酵素反応の結果放出される色素の可視
吸収スペクトルの吸収極大波長が大きくしかも分子吸光
係数が大きいので好ましい。次に、上記一般式(I)ま
たは(II)で表わされる化合物の具体例を示すが、本
発明の範囲はこれらの化合物のみに限定されるものでは
ない。[Chemical 2] (In the formula, M is a hydrogen atom, a sodium atom or a potassium atom, one of R 1 and R 2 is a methylsulfonyl group,
The other of R 1 and R 2 is a nitro group, R 3 is a chlorine atom or a hydrogen atom, R 4 is a hydrogen atom, a hydroxyl group, a methyl group or a methylcarbonylamino group, and R 5 is a hydrogen atom or a chlorine atom. And R 6 is a methyl group or 3
A sulfamoylphenyl group. ) Each of the compounds represented by the general formula (I) or (II) is hydrolyzed by the action of alkaline phosphatase at a rate proportional to the activity of alkaline phosphatase to release the corresponding azo dye. Can be used as In particular, a compound in which R 4 and R 5 are hydrogen atoms in the general formula (I) is easily available as a raw material, and the visible absorption spectrum of a dye released as a result of an enzymatic reaction has a large absorption maximum wavelength and a large molecular absorption coefficient. It is preferable because it is large. Next, specific examples of the compounds represented by the above general formula (I) or (II) are shown, but the scope of the present invention is not limited to these compounds.
【化3】 [Chemical 3]
【化4】 [Chemical 4]
【化5】 [Chemical 5]
【化6】 [Chemical 6]
【化7】 まず、芳香族アミンA−NH2(III)とフェノール
誘導体H−B−OHとを常法によりジアゾカップリング
させてアゾ色素(A−N=N−B−OH)(IV)を合
成する。なお、Aに強い電子吸引性基であるメチルスル
ホニル基とニトロ基が存在するため、ジアゾ化によって
生じるジアゾニウム塩を合成するにあたってはいわゆる
ニトロシル硫酸法(たとえばS.R.Sandlerお
よびW.Karo著〔Organic Functio
nal Group Preparations」第2
巻、295頁(1971年 Academic Pre
ss発行)に具体例が記載されている。)を用いること
が好ましい。 次いでピリジンの存在下にアゾ色素(IV)を大過剰の
オキシ塩化リンと反応させてホスホロジクロリデート
(V)とした後、(V)を水と反応させてリン酸モノエ
ステル(I′)とする。 (IV)より(V)を得る反応においては、(IV)の
3倍モル以上、好ましくは3倍ないし10倍モルのオキ
シ塩化リンをアセトン、トリメチルリン酸あるいはアセ
トンとトリメチルリン酸との混合溶媒にて2ないし50
倍、好ましくは5〜10倍に希釈した溶液に−15℃な
いし10℃、好ましくは−10℃ないし0℃で、(I
V)をピリジン、ピリジンを含むアセトン、ピリジンを
含むトリメチルリン酸、あるいはピリジンを含むアセト
ンとトリメチルリン酸との混合溶媒に溶かした溶液を滴
下することにより、ほとんど副生成物が生じることなく
(IV)を(V)へ変換することができることを見出し
た。なお、ピリジンの代りに、トリエチルアミン等のピ
リジンより塩基性の強い3級アミンを(IV)の溶液に
加えてもさしつかえない。(V)の生成はシリカゲル薄
層クロマトグラフィーにおいて(IV)よりもRf値の
小さいスポットが出現することによって確認できる。従
来たとえばp−ニトロフェニルホスホロジクロリデート
のごときアリールホスホロジクロリデートはオキシ塩化
リンとフェノールとを塩化カリウムなどの存在下に加熱
還流することにより合成されていた。その具体例は、た
とえば向山および橋本著、Bulletin of t
heChemical Society of Jap
an誌、第44巻、196頁(1971年発行)に記載
されている。しかしこのような激しい条件下では、上記
化合物(V)は効率よく生成しなかった。(V)を
(I′)ヘ変換する際には、(V)を単離せずに反応液
に水を加えればよい。ただし酸性条件下では(I′)が
分解することがあるから(V)と水との反応に際しては
発生する塩化水素を捕捉し得るピリジン等の三級アミン
を加えるか酢酸エチルなどの水に不溶な溶媒を共存させ
て水−油の2層系とすることによって好ましい結果が得
られることがある。こうして得た(I′)に濃い水酸化
ナトリウムあるいは水酸化カリウムの水溶液を加えて溶
解しpHを約10に調節した後不溶部を濾去して得た溶
液をその約10〜20倍容のエタノール中に撹拌しつつ
滴下することによって(I)または(II)の結晶を得
ることができる。 こうして得た化合物(I)または(II)を少量の水に
溶かした後、エタノール中に注入して晶折することによ
り精製を行なうことができる。なお、この方法によって
得た結晶には、1分子あたり数分子の結晶水を含むこと
が多い。以上のようにして合成した上記一般式(I)ま
たは(II)で表わされる本発明の化合物はアルカリ性
ホスファターゼ定量用基質として優れている。すなわち
上記一般式(I)または(II)で表わされる化合物
は、(1)アルカリ性ホスファターゼの作用によって、
アルカリ性ホスファターゼの活性度に比例した速度で加
水分解されてアゾフェノール色素を与え、(2)これら
の色素は、従来広く行なわれてきさp−ニトロフェニル
リン酸二ナトリウムを基質として用いる方法における呈
色色素であるp−ニトロフェノールよりも長波長側に可
視光吸収極大を有するので、それだけ血中色素等の有色
物質による妨害を受け難く、(3)かつこれらの色素は
水溶性であるため、酵素活性測定中に凝集や沈澱を起こ
すことがなく、したがってアルカリ性ホスファターゼ定
量用基質として使用した場合、定量試験条件設定の自由
度が高く、(4)しかも合成例に示す通り合成に難点が
なく、本明細書の冒頭に述べたとおりリン酸フタレイ
ン、リン酸チモールフタレイン、あるいはチモールブル
ーモノホスフェイトの合成においては化合物の単離精製
操作が繁雑であるのとは対照的に、通常の晶析によって
精製できる。本発明の化合物を用いてアルカリ性ホスフ
ァターゼを定量するには、Bessey−Lowry法
(Journal of Biological Ch
emistry誌、第164巻、321頁、1946年
発行に記載されている。)におけるp−ニトロフェニル
リン酸二ナトリウムのかわりに本発明の化合物を用い、
Bessey−Lowry法において酵素反応の結果生
じるp−ニトロフェノールの量を求めるかわりに本発明
の化合物から生じるアゾ色素A−N=N−B−OHの量
を求めればよい。例えば、まず、一般式(I)または
(II)にて示される化合物をpH10前後の緩衝液に
溶解し基質液を調製する。このとき、基質液に、酵素活
性化剤(例えば塩化マグネシウム)などを添加すると好
ましい。次に、この基質液に、被測定物であるアルカリ
性ホスファターゼを含有する液を添加し反応を行なわし
める。このとき、一般式(I)または(II)で示され
る化合物は、基質液中に1〜20ミリモル/リットルの
濃度で存在しているのが好ましい。また、一般式(I)
または(II)で示される化合物は、アルカリ性ホスフ
ァターゼに対して、大過剰に、すなわちモル比では10
倍以上存在していることが好ましい。上記反応は、10
〜50℃より好ましくは30〜40℃の温度にて、10
〜60分間の時間にて行なわれる。次に、必要に応じ
て、溶液のpHを塩基または酸を添加して上げたり、下
げたり、場合によっては、DMF(ジメチルホルムアミ
ド)、メチルセロソルプ等の有機溶剤を添加してこの反
応を停止させこのときの生成したアゾ色素の濃度を分光
光度計などによって濃度測定することによって、必要に
より、検量線からアルカリ性ホスファターゼを定量す
る。比色波長は当該色素の吸収極大波長付近に設定すれ
ばよいが、比色の際にシクロデキストリン類好ましくは
α−シクロデキストリンを添加することにより吸収極大
波長を長波長側へシフトさせることも可能である。この
とき、シクロデキストリン類の添加量は、比色液1ml
当り0.1mgないし20mg、好ましくは1mgない
し10mgである。次に、本発明の一般式(I)または
(II)で表わされる化合物のうち化合物3について合
成例を示す。化合物3以外のものについても前述の合成
法に基づき、また下記の記載に順じて容易に合成するこ
とができる。 合成例:化合物3の合成 オキシ塩化リン4mlとアセトン20mlとを混合し−
8℃に冷却した。この溶液に、4−(2−メタンスルホ
ニル−4−ニトロフェニルアゾ)フェノール2gをアセ
トン20ml、トリメチルリン酸10ml、ピリジン8
ml、およびトリエチルアミン0.5mlに溶かした溶
液を25分間にわたって滴下した。この間、反応液の温
度が0℃を越えぬように外部から冷却した。さらに30
分間0℃以下で撹拌を続けた後、30mlの水を滴下し
た。室温で10分間撹拌した後、200mlの飽和食塩
水と氷との混合物中に注入し、生じた結晶を濾取した。
この結晶に1規定の水酸化ナトリウム水溶液20mlを
加えpHを約10とした。不溶部を濾却した後、濾液を
エタノール150ml中に注入し、生じた結晶を濾取し
エタノールで洗浄し、減圧下に乾燥した。 収量2g、λmax 0.02N−NaOH 382nm 次に、本発明の化合物を用いてアルカリ性フォスファタ
ーゼを定量する方法の具体例を示す。 参考例1. 基質液の調製:化合物3の結晶35.05mgを10m
lのグリシン緩衝液(pH10、0.5mmole/リ
ットルの塩化マグネシウムを含む)に溶かした。 酵素液の調製:シグマケミカル社アルカリ性ホスファタ
ーゼType I約6mgを20mlの蒸留水に溶かし
た液および、この液を2倍および4倍に希釈した液を3
種類調製した。 操作:基質液1mlを試験管に入れ37℃に3分間加温
した。酵素液0.1mlを加え、37℃で30分間加温
し反応させた後0.02規定の水酸化ナトリウム水溶液
10mlを加えて反応を停止した。酵素液のかわりに蒸
留水を用いる点を除いて全く同様に処理した盲検液を対
照として520nmで吸光度(ΔOD)を測定した。こ
のようにして、濃度の異なった3種類の酵素液について
各々測定を行なった。これらと同じ酵素液についてBe
ssey−Lowry法を適用した場合の410nmに
おける盲検液を対照とした吸光度(ΔOD)を測定し
た。 なおBessey−Lowry法の操作は上記化合物3
の結晶35.05mgのかわりにp−ニトロフェニルリ
ン酸ナトリウム20mgを用いて410nmで比色する
他は上記の操作と全く同様である。これら2つの方法に
よるΔODの値の関係を図1に示した。この図1から次
のことが明らかとなった。 (1) 酵素濃度に比例して、すなわちBessey−
Lowry法による値に比例してΔODが変化するので
ΔODの値から酵素の活性を求めることができる。 (2) 化合物3を基質とした場合のΔODはBess
ey−Lowry法のΔODより大きな割合で変化して
いるので(直線の勾配が1以上)、化合物3を基質とし
た場合のほうがBessey−Lowry法より感度が
高い。 (3) 化合物3を基質とした場合には520nmで比
色できるので、410nmで比色するBessey−L
owry法より、血中の色素などの有色物質による妨害
を受け難い。 このように本発明の化合物は、アルカリ性ホスファター
ゼの定量用基質として好適な化合物であることがわか
る。 参考例2.参考例1の化合物3の結晶35.05mgの
かわりに48.18mgの化合物12の結晶を用い、吸
光度の測定を520nmではなく644nmで行なう他
は参考例1と同様の操作を行なった。結果を図2に示し
た。この図2から次のことが明らかである。 (1)酵素濃度に比例して、すなわちBessey−L
owry法による値に比例してΔODが変化するのでΔ
ODの値から酵素の活性を求めることができる。 (2) 化合物12を基質とした場合には、644nm
で比色できるので、410nmで比色するBessey
−Lowry法より血中の色素などの有色物質に妨害を
受け難い。 このように本発明の化合物は、アルカリ性ホスファター
ゼの定量用基質として好適な化合物であることがわか
る。[Chemical 7] First, the aromatic amine A-NH 2 (III) and the phenol derivative H-B-OH are diazo-coupled by a conventional method to synthesize an azo dye (A-N = N-B-OH) (IV). Since A has a strong electron-withdrawing group such as a methylsulfonyl group and a nitro group, the so-called nitrosyl sulfuric acid method (for example, SR Sandler and W. Karo [[ Organic Function
nal Group Preparations "No. 2
Volume, 295 pages (1971 Academic Pre
Specific examples are described in (issued by ss). ) Is preferably used. Then, the azo dye (IV) is reacted with a large excess of phosphorus oxychloride in the presence of pyridine to form a phosphorodichloridate (V), and then (V) is reacted with water to form a phosphoric acid monoester (I ′). And In the reaction for obtaining (V) from (IV), 3 times or more, preferably 3 to 10 times, mol of phosphorus oxychloride is added to acetone, trimethylphosphoric acid or a mixed solvent of acetone and trimethylphosphoric acid in (IV). At 2 to 50
A solution diluted to 1 ×, preferably 5 to 10 times, at −15 ° C. to 10 ° C., preferably −10 ° C. to 0 ° C., (I
V) is added dropwise to a solution of pyridine, pyridine-containing acetone, pyridine-containing trimethylphosphoric acid, or a mixed solvent of pyridine-containing acetone and trimethylphosphoric acid, to thereby produce almost no by-products (IV ) Can be converted to (V). It should be noted that a tertiary amine having a stronger basicity than pyridine such as triethylamine may be added to the solution of (IV) instead of pyridine. The formation of (V) can be confirmed by the appearance of spots having a smaller Rf value than that of (IV) in silica gel thin layer chromatography. Conventionally, aryl phosphorodichloridates such as p-nitrophenyl phosphorodichloridate have been synthesized by heating and refluxing phosphorus oxychloride and phenol in the presence of potassium chloride and the like. Specific examples thereof include, for example, Mukaiyama and Hashimoto, Bulletin of
heChemical Society of Japan
An magazine, Vol. 44, page 196 (published in 1971). However, under such violent conditions, the above compound (V) was not efficiently produced. When converting (V) to (I ′), water may be added to the reaction solution without isolating (V). However, since (I ') may decompose under acidic conditions, a tertiary amine such as pyridine capable of trapping hydrogen chloride generated during the reaction of (V) with water is added or it is insoluble in water such as ethyl acetate. A preferable result may be obtained by making a water-oil two-layer system coexist with another solvent. A solution of concentrated sodium hydroxide or potassium hydroxide was added to the thus obtained (I ') to dissolve it, the pH was adjusted to about 10, and the insoluble portion was filtered off to obtain a solution of about 10 to 20 times its volume. The crystal of (I) or (II) can be obtained by adding dropwise to ethanol with stirring. The compound (I) or (II) thus obtained can be purified by dissolving it in a small amount of water, injecting it into ethanol and crystallizing. The crystals obtained by this method often contain several molecules of crystal water per molecule. The compound of the present invention represented by the above general formula (I) or (II) synthesized as described above is excellent as a substrate for quantifying alkaline phosphatase. That is, the compound represented by the above general formula (I) or (II) can be produced by the action of (1) alkaline phosphatase.
It is hydrolyzed at a rate proportional to the activity of alkaline phosphatase to give azophenol dyes. (2) These dyes have been widely used in the prior art, and coloration in the method using disodium p-nitrophenylphosphate as a substrate. Since it has a maximum absorption of visible light on the longer wavelength side than p-nitrophenol, which is a dye, it is less susceptible to interference by colored substances such as blood dye, and (3) and these dyes are water-soluble, so the enzyme When used as a substrate for alkaline phosphatase quantification, it does not cause aggregation or precipitation during the activity measurement, and thus the degree of freedom in setting quantitative test conditions is high, and there are no difficulties in synthesis as shown in (4) Synthesis example. As mentioned at the beginning of the description, phthalein phosphate, thymolphthalein phosphate, or thymol blue monophosphate Isolation purification of the compounds in the synthesis of a complex, in contrast, can be purified by conventional crystallization. For quantifying alkaline phosphatase using the compound of the present invention, the Bessey-Lowry method (Journal of Biological Ch.
It is described in the magazine, 164, 321 pages, published in 1946. ), Using the compound of the present invention in place of p-nitrophenyl phosphate disodium,
Instead of determining the amount of p-nitrophenol resulting from the enzymatic reaction in the Bessey-Lowry method, the amount of azo dye A-N = N-B-OH generated from the compound of the present invention may be determined. For example, first, the compound represented by the general formula (I) or (II) is dissolved in a buffer solution having a pH of about 10 to prepare a substrate solution. At this time, it is preferable to add an enzyme activator (eg, magnesium chloride) to the substrate solution. Next, a liquid containing alkaline phosphatase, which is the substance to be measured, is added to the substrate liquid to carry out the reaction. At this time, the compound represented by the general formula (I) or (II) is preferably present in the substrate solution at a concentration of 1 to 20 mmol / liter. In addition, the general formula (I)
Alternatively, the compound represented by (II) is used in a large excess with respect to alkaline phosphatase, that is, in a molar ratio of 10
It is preferably present twice or more. The above reaction is 10
10 to 50 ° C, more preferably 30 to 40 ° C.
~ 60 minutes. Then, if necessary, the pH of the solution is increased or decreased by adding a base or an acid, and in some cases, an organic solvent such as DMF (dimethylformamide) or methylcellosolve is added to stop the reaction. At this time, the concentration of the azo dye thus formed is measured by a spectrophotometer or the like, and if necessary, alkaline phosphatase is quantified from the calibration curve. The colorimetric wavelength may be set near the absorption maximum wavelength of the dye, but it is also possible to shift the absorption maximum wavelength to the long wavelength side by adding cyclodextrin, preferably α-cyclodextrin, at the time of colorimetry. Is. At this time, the amount of cyclodextrins added was 1 ml of the colorimetric liquid.
The amount is 0.1 mg to 20 mg, preferably 1 mg to 10 mg. Next, among the compounds represented by the general formula (I) or (II) of the present invention, a synthesis example of the compound 3 will be shown. Compounds other than Compound 3 can be easily synthesized based on the above-mentioned synthetic method and in accordance with the following description. Synthesis example: Synthesis of compound 3 Phosphorus oxychloride 4 ml and acetone 20 ml were mixed-
Cooled to 8 ° C. To this solution, 2 g of 4- (2-methanesulfonyl-4-nitrophenylazo) phenol was added with 20 ml of acetone, 10 ml of trimethylphosphoric acid, and 8 parts of pyridine.
ml, and a solution of triethylamine in 0.5 ml was added dropwise over 25 minutes. During this time, the reaction solution was cooled from the outside so that the temperature did not exceed 0 ° C. 30 more
After continuing stirring at 0 ° C. or less for 30 minutes, 30 ml of water was added dropwise. After stirring at room temperature for 10 minutes, the mixture was poured into 200 ml of a saturated saline solution and ice, and the resulting crystals were collected by filtration.
20 ml of a 1N aqueous sodium hydroxide solution was added to the crystals to adjust the pH to about 10. After filtering off the insoluble portion, the filtrate was poured into 150 ml of ethanol, and the generated crystals were collected by filtration, washed with ethanol, and dried under reduced pressure. Yield 2 g, λ max 0.02 N-NaOH 382 nm Next, a specific example of a method for quantifying alkaline phosphatase using the compound of the present invention will be shown. Reference example 1. Preparation of substrate solution: Compound 3 crystal (35.05 mg) in 10 m
It was dissolved in 1 glycine buffer (pH 10, containing 0.5 mmole / liter of magnesium chloride). Preparation of Enzyme Solution: A solution prepared by dissolving about 6 mg of alkaline phosphatase Type I of Sigma Chemical Co. in 20 ml of distilled water and a solution prepared by diluting this solution 2 times and 4 times 3 times.
Kind prepared. Procedure: 1 ml of the substrate solution was placed in a test tube and heated to 37 ° C for 3 minutes. The enzyme solution (0.1 ml) was added, and the mixture was heated at 37 ° C. for 30 minutes for reaction, and then the reaction was stopped by adding 0.02 N sodium hydroxide aqueous solution (10 ml). The absorbance (ΔOD) was measured at 520 nm using a blind solution treated in exactly the same manner except that distilled water was used instead of the enzyme solution. In this way, measurement was performed for each of the three types of enzyme solutions having different concentrations. Be for the same enzyme solutions as these
When the ssey-Lowry method was applied, the absorbance (ΔOD) at 410 nm using the blind solution as a control was measured. The operation of the Bessey-Lowry method was carried out according to the above compound 3
The procedure is exactly the same as that described above, except that 20 mg of sodium p-nitrophenylphosphate is used instead of 35.05 mg of the crystal of Example 1 above to perform colorimetry at 410 nm. The relationship between the ΔOD values obtained by these two methods is shown in FIG. The following is clear from FIG. (1) In proportion to the enzyme concentration, that is, Bessey-
Since ΔOD changes in proportion to the value obtained by the Lowry method, the activity of the enzyme can be determined from the value of ΔOD. (2) ΔOD when using Compound 3 as a substrate is Bess
Since the change is at a rate larger than the ΔOD of the ey-Lowry method (the slope of the straight line is 1 or more), the compound 3 as a substrate has higher sensitivity than the Bessey-Lowry method. (3) When Compound 3 is used as a substrate, colorimetry can be performed at 520 nm, and therefore Bessey-L that is colorimetric at 410 nm
Less likely to be disturbed by colored substances such as pigments in blood than the owry method. As described above, it is understood that the compound of the present invention is a compound suitable as a substrate for quantifying alkaline phosphatase. Reference example 2. The procedure of Reference Example 1 was repeated, except that 48.18 mg of the crystal of Compound 12 was used instead of 35.05 mg of the crystal of Compound 3 of Reference Example 1, and the absorbance was measured at 644 nm instead of 520 nm. The results are shown in Fig. 2. The following is clear from FIG. (1) In proportion to the enzyme concentration, that is, Bessey-L
Since ΔOD changes in proportion to the value by the owry method, Δ
The activity of the enzyme can be determined from the value of OD. (2) When compound 12 is used as a substrate, 644 nm
Color comparison can be done at 410nm.
-It is less likely to be disturbed by colored substances such as pigments in blood than the Lowry method. As described above, it is understood that the compound of the present invention is a compound suitable as a substrate for quantifying alkaline phosphatase.
【図1】化合物3を用いてアルカリ性ホスファターゼを
測定したときの結果を示すグラフである。FIG. 1 is a graph showing the results when alkaline phosphatase was measured using Compound 3.
【図2】化合物12を用いてアルカリ性ホスファターゼ
を測定したときの結果を示すグラフである。図1および
図2において、横軸はBessey−Lowry法を用
いた場合の吸光度(ΔOD)であり縦軸は本発明の化合
物を基質として用いた場合の吸光度(ΔOD)である。FIG. 2 is a graph showing the results when alkaline phosphatase was measured using Compound 12. 1 and 2, the horizontal axis is the absorbance (ΔOD) when the Bessey-Lowry method is used, and the vertical axis is the absorbance (ΔOD) when the compound of the present invention is used as a substrate.
Claims (1)
リン酸エステル。 【化1】 (式中、Mは水素原子、ナトリウム原子またはカリウム
原子であり、R1とR2の一方はメチルスルホニル基、
R1とR2の他方はニトロ基であり、R3は塩素原子ま
たは水素原子、R4は水素原子、ヒドロキシル基、メチ
ル基またはメチルカルボニルアミノ基であり、R5は水
素原子または塩素原子であり、R6はメチル基または3
−スルファモイルフェニル基である。)1. A phosphoric acid ester represented by the general formula (I) or (II). [Chemical 1] (In the formula, M is a hydrogen atom, a sodium atom or a potassium atom, one of R 1 and R 2 is a methylsulfonyl group,
The other of R 1 and R 2 is a nitro group, R 3 is a chlorine atom or a hydrogen atom, R 4 is a hydrogen atom, a hydroxyl group, a methyl group or a methylcarbonylamino group, and R 5 is a hydrogen atom or a chlorine atom. And R 6 is a methyl group or 3
A sulfamoylphenyl group. )
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13381591A JPH07103134B2 (en) | 1991-03-29 | 1991-03-29 | Phosphate ester |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13381591A JPH07103134B2 (en) | 1991-03-29 | 1991-03-29 | Phosphate ester |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP56044325A Division JPS57159499A (en) | 1981-03-26 | 1981-03-26 | Substrate for determining alkaline phosphatase and determining method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0733789A JPH0733789A (en) | 1995-02-03 |
| JPH07103134B2 true JPH07103134B2 (en) | 1995-11-08 |
Family
ID=15113690
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13381591A Expired - Lifetime JPH07103134B2 (en) | 1991-03-29 | 1991-03-29 | Phosphate ester |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH07103134B2 (en) |
-
1991
- 1991-03-29 JP JP13381591A patent/JPH07103134B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0733789A (en) | 1995-02-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2235977T3 (en) | ANALOGS OF 8- (ANILINO) -1-NAFTALENOSULFONATO AND ITS USE IN ANALYTE DETECTION TESTS. | |
| US4336331A (en) | Method for assaying the activity of γ-glutamyl transpeptidase in serum | |
| JPH0426624B2 (en) | ||
| JPH0764986B2 (en) | New coloring reagent | |
| JP2002520448A (en) | New fluorogenic substrate for hydrolase | |
| IL43735A (en) | Derivatives of gamma-glutamyl-4-nitroanilide and process for the preparation thereof | |
| JPS6349189B2 (en) | ||
| JP3312793B2 (en) | Arylazochromoionophores and methods for measuring calcium ions using the same | |
| EP0061731B2 (en) | Novel phosphoric ester and a method for quantitative analysis of an alkaline phosphatase using the same as a substrate | |
| US4719097A (en) | Phosphates of resorufin derivatives and compositions thereof for the determination of the activity of phosphatases | |
| JPH07103134B2 (en) | Phosphate ester | |
| EP0137177B1 (en) | Chromogene and fluorogene carboxylic-acid esters, method for their preparation and agents for the detection and determination of hydrolases | |
| CN108218817B (en) | A kind of differentiation GSH, Cys, SO2Fluorescence probe and its preparation method and application | |
| US5081274A (en) | 4-acyl-2,6-dihalophenyl-phosphoric acid derivatives useful in the determination of acid phosphatase activity | |
| JPS63216499A (en) | Determination of phosphatase activity | |
| JPH01160990A (en) | 1-naphtholphthalein monophosphate, its production, measurement of alkali phosphatase and diagnostic agent for detecting alkali phosphatase | |
| JPH0631294B2 (en) | Novel glucosamine derivative, enzyme activity measuring reagent and enzyme activity measuring method using the same | |
| JPS6131096B2 (en) | ||
| US4983756A (en) | Novel choline derivative and method for detemining serum cholinesterase activity using the same | |
| US4822891A (en) | 4-amino-2,3-di-substituted-1-(mono- or trichlorophenyl)-3-pyrazolin-5-ones | |
| JPH04253991A (en) | Novel galactopyranoside, preparation thereof and process and reagent for detecting analytical object in test solution using beta- galactosedase substrate comprising the same and cedia-system | |
| JPS6121546B2 (en) | ||
| JPH0599A (en) | Determination of phosphatase activity | |
| JPH01112155A (en) | Method for determination of hydrogen peroxide and reagent for said determination | |
| EP0350808A2 (en) | Method for detecting substances with hydrolase activity |